MI
48109, United States
Available to mentor
Dr. Hallie Prescott is an Associate Professor in Pulmonary & Critical Care Medicine at the University of Michigan and a staff physician the Ann Arbor Veterans Affairs Healthcare System. She completed pulmonary/critical care fellowship training in 2014 and currently attends in the Ann Arbor VA outpatient pulmonary clinic and medical intensive care unit, as well as in the Critical Care Medicine Unit at Michigan Medicine. She has a master’s degree in healthcare research, with broad methodological expertise in quantitative, qualitative, and survey research methods. The primary focus of her research program has been on sepsis care and outcomes. She serves as co-chair of the international Surviving Sepsis Campaign Guidelines and leads the Michigan Hospital Medicine Safety Consortium’s Sepsis Initiative. Dr. Prescott’s research contributions have been recognized by awards from American Thoracic Society, American Society of Clinical Innovation, Australia/New Zealand Intensive Care Society, and the Carol A. Kauffman MD Department of Internal Medicine Early Career Endowment Award (2019-2024) from the University of Michigan.
-
MSc, Healthcare ResearchUniversity of Michigan, Ann Arbor, 2014
-
MDThe Ohio State University, Columbus, 2007
-
BAMiddlebury College, Middlebury, 2003
-
Center MemberCenter for Integrative Research in Critical Care
-
Center MemberInstitute for Healthcare Policy and Innovation
Dr. Hallie Prescott's research focuses on the measurement, management, and outcomes of sepsis.
-
Admon AJ, Sjoding MW, Prescott HC, Chanderraj R, Dickson RP. Am J Respir Crit Care Med, 2024 Nov 12;Journal ArticleEstimating the Population-Level Impact of Empiric Anti-Anaerobic Antibiotics among US Adults Hospitalized with Sepsis.
DOI:10.1164/rccm.202405-0955RL PMID: 39531631 -
Prescott HC, Heath M, Munroe ES, Blamoun J, Bozyk P, Hechtman RK, Horowitz JK, Jayaprakash N, Kocher KE, Younas M, Taylor SP, Posa PJ, McLaughlin E, Flanders SA. Chest, 2024 Nov; 166 (5): 1035 - 1045.Journal ArticleDevelopment and Validation of the Hospital Medicine Safety Sepsis Initiative Mortality Model.
DOI:10.1016/j.chest.2024.06.3769 PMID: 38964673 -
Carlton EF, Rahman M, Maddux AB, Weiss SL, Prescott HC. Crit Care Med, 2024 Nov 1; 52 (11): 1700 - 1709.Journal ArticleFrequency of and Risk Factors for Increased Healthcare Utilization After Pediatric Sepsis Hospitalization.
DOI:10.1097/CCM.0000000000006406 PMID: 39297738 -
Baillie JK, Angus D, Burnham K, Calandra T, Calfee C, Gutteridge A, Hacohen N, Khatri P, Langley R, Ma'ayan A, Marshall J, Maslove D, Prescott HC, Rowan K, Scicluna BP, Seymour C, Shankar-Hari M, Shapiro N, Joost Wiersinga W, Singer M, Randolph AG. Intensive Care Med, 2024 Dec; 50 (12): 2031 - 2042.Journal ArticleCausal inference can lead us to modifiable mechanisms and informative archetypes in sepsis.
DOI:10.1007/s00134-024-07665-4 PMID: 39432104 -
Kullberg RFJ, Haak BW, Chanderraj R, Prescott HC, Dickson RP, Wiersinga WJ. Lancet Respir Med, 2024 Oct 11;Journal ArticleEmpirical antibiotic therapy for sepsis: save the anaerobic microbiota.
DOI:10.1016/S2213-2600(24)00257-1 PMID: 39401510 -
Seelye S, Cano J, Hogan CK, Prescott HC, Sussman JB. J Gen Intern Med, 2024 Oct 7;Journal ArticleSocial Determinants of Health and Risk-Adjusted Sepsis Mortality in the Nationwide Veterans Affairs Healthcare System.
DOI:10.1007/s11606-024-09104-y PMID: 39375318 -
Tirumalasetty J, Miller SA, Prescott HC, DeTata S, Arroyo AC, Wilkinson AJK, Rabin AS. JAMA, 2024 Sep 24; 332 (12): 1017 - 1019.Journal ArticleGreenhouse Gas Emissions and Costs of Inhaler Devices in the US.
DOI:10.1001/jama.2024.15331 PMID: 39207797 -
Admon AJ, Cohen-Mekelburg S, Opatrny M, Lee KT, Law AC, Gershengorn HB, Valley TS, Prescott HC, Wiktor MJ, Neeluru J, Cooke CR, Weissman GE. Crit Care Med, 2024 Sep 1; 52 (9): 1323 - 1332.Journal ArticleTwo Weeks Versus One Week of Maximal Patient-Intensivist Continuity for Adult Medical Intensive Care Patients: A Two-Center Target Trial Emulation.
DOI:10.1097/CCM.0000000000006322 PMID: 38713002
